Navigation Links
Edwards Lifesciences Reports Strong First Quarter Results and Raises 2008 Guidance

, except per share data) 2008 2007

GAAP net income $18.2 $33.2

Reconciling items:

Special charges, net

1) Loss on sale of product line 8.1 -

2) Litigation settlement 2.1 -

3) Realignment expenses, net (0.1) -

Total special charges, net 10.1 -

Provision for income taxes

Tax effect on non-GAAP

adjustments (A) 4.9 -

Total provision for income

taxes, net 4.9 -

Non-GAAP net income $33.2 $33.2

Non-GAAP earnings per share:

Basic non-GAAP earnings per share $0.59 $0.57

Diluted non-GAAP earnings per share (B) $0.56 $0.54

Non-GAAP weighted average shares


Basic 56.1 57.9

Diluted 61.2 63.5

Notes 1 - 3: See description of Special Charges, net on the previous


(A) The tax effect on non-GAAP adjustments is calculated using the

relevant tax jurisdictions' statutory tax rates.

(B) Diluted non-GAAP earnings per share is calculated by adding back to

net income $1.0 million for the quarter in interest expense related to

the convertible debt, then dividing by the weighted average diluted

shares outstanding.

Note: Numbers may not calculate due to rounding


Unaudited Reconciliation of Sales by Product Line and Region

(in millions)

2008 Adjusted

SOURCE Edwards Lifesciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Edwards Lifesciences Celebrates 50 Years of Life-Saving Innovations
2. Lambert, Edwards & Associates Named Agency of Record for The West Michigan Science & Technology Initiative
3. Edwards Lifesciences Announces First Human Implants of Next-Generation Transcatheter Heart Valve
4. Edwards Lifesciences Announces Organizational Changes
5. Edwards Lifesciences to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
6. Edwards Lifesciences to Host Earnings Conference Call on February 5, 2008
7. Edwards Lifesciences Receives FDA Approval to Add Transapical Delivery System to U.S. Clinical Trial of Transcatheter Heart Valve
8. Edwards Lifesciences Completes Acquisition of CardioVations Product Line
9. Edwards Lifesciences Forecasts Strong Growth in 2008
10. Marshall Edwards, Inc. to Present at BIO Investor Forum 2007
11. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
Post Your Comments:
(Date:10/7/2015)... ... October 07, 2015 , ... ... webinar titled Smart Nanostructured Coatings to provide a comprehensive overview of the innovations ... free webinar at . This webinar will be given by Professor ...
(Date:10/7/2015)... Menlo Park, CA and Yokahama, Japan (PRWEB) , ... ... ... Sugiyama Lab at RIKEN have entered into a collaborative agreement to develop a ... interactions (DDIs). , Optivia and the Sugiyama Lab will combine their respective ...
(Date:10/6/2015)... ... October 06, 2015 , ... Researchers ... microscope technology that could help surgeons work with a greater degree of accuracy. ... blood flow and cancerous tissue over real images of blood vessels and other ...
(Date:10/6/2015)... , Oct. 6, 2015  The nonprofit ... that natural ingredients manufacturer Teawolf has adopted the ... Adopt-an-Herb Program . HerbMedPro ™ database ... clinical research on guayusa, a caffeine-containing member of ... comprehensive database available on ABC,s website that provides ...
Breaking Biology Technology:
... Networks Corp. has been recognized by Microsoft ... services. , ,The Madison-based IT solutions provider this month ... Midwest to achieve Microsoft's Enterprise Project Management (EPM) specialization. ... expertise in serving businesses that require the tools and ...
... Wis. Higher revenue from its clinical molecular diagnostic products ... a loss for the quarter ending March 31, 2006. , ,Third ... of $4.4 million, or ($0.11) a diluted share, for the first ... net loss of $4.4 million, or ($0.11) a diluted share, for ...
... Wis. Fiserv, which provides software and services ... revenues in 2006 were up 13 percent to $1.1 ... from the $140 million the company made in the ... , ,Fiserve's activities in the first quarter included repurchasing ...
Cached Biology Technology:
(Date:9/28/2015)... , September 28, 2015 ... Component (Hardware & Software), Product (Scanner & Others), Application ... & Defense, & Others) & Geography Global - Forecast ... expected to reach USD 3627.90 Million by 2020, at ... Browse 65 market data T ables ...
(Date:9/24/2015)... , Sept. 24, 2015  EyeLock LLC, a ... showcasing its award winning and latest technology in Booth ... Anaheim, California . EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:9/10/2015)... LONDON , Sept. 10, 2015 ... This New Study Reveals Selling Opportunities and Revenue ... What,s the future of biologics, especially new drug ... You will stay ahead with exclusive market data ... can explore trends, developments, results, opportunities and sales ...
Breaking Biology News(10 mins):
... is often compared to a book. However, it is not so ... rather like a cookbook. The cell reads only those recipes which ... genes; ,reading, in the book of the cell means creating RNA ... The cell uses highly complex, sophisticated regulatory mechanisms to ...
... have created mice that can "smell" light, providing a potent ... basis of olfaction. The work, described this week in ... future study of smell and of complex perception systems that ... "It makes intuitive sense to use odors to study ...
... thousand federal, state and local leaders and physical security ... Regional Airport next May 17-19 to observe demonstrations of ... to personnel, equipment and facilities - in combat zones ... and abroad. Military and civilian representatives of ...
Cached Biology News:
... for all types of yeast two-hybrid studies, including complex ... Choice of two bait vectors for maximum ... Triple reporter strain NMY51 ... Complete set of controls: pLexA-p53, pLexA-lamin ...
... Quickly, effectively seals labware. Waterproof, ... protects anhydrous materials. Can be folded ... without rupturing. Stretched lengthwise at 21C ... Yet when tension is removed, film ...
Human Serum FDA Licensed US Donor Centers Sterile / Non-sterile: Sterile Filtered to 0.2 micron Information: Extensive Viral Testing ...
Normal human serum collected off the clot from healthy normal humans. Each donor unit is negative for anti-HIV 1&2, HIV-Ag, HCV, and HBsAg by FDA required tests...
Biology Products: